CLINICAL_TRIALS
trial_result
· 2026-04-13
Clinical Trial Update: A Study to Evaluate Setanaxib in Patients With Alport Syndrome [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating setanaxib in patients with Alport syndrome has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Calliditas Therapeutics AB | Conditions: Alport Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-04-13